Non-inferiority trials are unethical because they disregard patients' interests
- 23 October 2007
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 370 (9602) , 1875-1877
- https://doi.org/10.1016/s0140-6736(07)61604-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Good Enough: A Primer on the Analysis and Interpretation of Noninferiority TrialsAnnals of Internal Medicine, 2006
- Clinical trials: active control vs placebo — What is ethical?Science and Engineering Ethics, 2004
- How can research ethics committees protect patients better?BMJ, 2003
- Non‐inferiority trials: design concepts and issues – the encounters of academic consultants in statisticsStatistics in Medicine, 2002
- Some fundamental issues with non‐inferiority testing in active controlled trialsStatistics in Medicine, 2002
- Does placebo help establish equivalence in trials of new antidepressants?European Psychiatry, 2000
- Randomized, Double-Blind Study Comparing Saruplase With Streptokinase Therapy in Acute Myocardial Infarction: The COMPASS Equivalence TrialJournal of the American College of Cardiology, 1998
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarctionPublished by Elsevier ,1992
- MEDICAL SCIENCE GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarctionThe Lancet, 1990